Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Lentini

Showing results (11-20 of 103) with videos related to

Pageof 11
Sort By:
Schizophrenia Research|July 10, 2019
The therapeutic power of greenGiovanni Lentini, Gualtiero Milani, Solomon Habtemariam
Drug Development Research|April 1, 2020
Repurposing therapeutic agents and herbal medicines to defeat viral nemesisLeonardo Caputo, Giovanni Lentini, Solomon Habtemariam
Current Medicinal Chemistry|May 18, 2016
Recent Trends in the Discovery of Small Molecule Blockers of Sodium ChannelsRoberta Gualdani, Maria Maddalena Cavalluzzi, Giovanni Lentini
Molecules (Basel, Switzerland)|April 23, 2020
COVID-19, Chloroquine Repurposing, and Cardiac Safety Concern: Chirality Might HelpGiovanni Lentini, Maria Maddalena Cavalluzzi, Solomon Habtemariam
Biochemical Pharmacology|May 30, 2026
Therapeutic potential of mitochonic acid (MA-5) in modulating mitochondrial function and inflammatory responses: A focus on carnitine/acylcarnitine carrier (SLC25A20) transport activityNicola Giangregorio, Lara Console, Giovanni Lentini, et al.
Frontiers in Microbiology|December 12, 2022
Editorial: Advances in the discovery of natural molecules and their analogues against microbial infection-related biofilmsLaura Quintieri, Sridhar Mani, Giovanni Lentini, et al.
Molecules (Basel, Switzerland)|November 16, 2016
The Chemistry and Pharmacology of Citrus LimonoidsRoberta Gualdani, Maria Maddalena Cavalluzzi, Giovanni Lentini, et al.
Biophysical Chemistry|July 5, 2017
Discovery of a new mexiletine-derived agonist of the hERG K<sup>+</sup> channelRoberta Gualdani, Maria Maddalena Cavalluzzi, Francesco Tadini-Buoninsegni, et al.
Molecules (Basel, Switzerland)|July 26, 2020
From Riluzole to Dexpramipexole via Substituted-Benzothiazole Derivatives for Amyotrophic Lateral Sclerosis Disease Treatment: Case StudiesSerge Mignani, Jean-Pierre Majoral, Jean-François Desaphy, et al.
Expert Opinion on Drug Discovery|August 18, 2017
Ligand efficiency metrics in drug discovery: the pros and cons from a practical perspectiveMaria Maddalena Cavalluzzi, Giuseppe Felice Mangiatordi, Orazio Nicolotti, et al.
Pageof 11

Showing results (11-20 of 103) with videos related to

Sort By:
Pageof 11
Schizophrenia Research|July 10, 2019
The therapeutic power of greenGiovanni Lentini, Gualtiero Milani, Solomon Habtemariam
Drug Development Research|April 1, 2020
Repurposing therapeutic agents and herbal medicines to defeat viral nemesisLeonardo Caputo, Giovanni Lentini, Solomon Habtemariam
Current Medicinal Chemistry|May 18, 2016
Recent Trends in the Discovery of Small Molecule Blockers of Sodium ChannelsRoberta Gualdani, Maria Maddalena Cavalluzzi, Giovanni Lentini
Molecules (Basel, Switzerland)|April 23, 2020
COVID-19, Chloroquine Repurposing, and Cardiac Safety Concern: Chirality Might HelpGiovanni Lentini, Maria Maddalena Cavalluzzi, Solomon Habtemariam
Biochemical Pharmacology|May 30, 2026
Therapeutic potential of mitochonic acid (MA-5) in modulating mitochondrial function and inflammatory responses: A focus on carnitine/acylcarnitine carrier (SLC25A20) transport activityNicola Giangregorio, Lara Console, Giovanni Lentini, et al.
Frontiers in Microbiology|December 12, 2022
Editorial: Advances in the discovery of natural molecules and their analogues against microbial infection-related biofilmsLaura Quintieri, Sridhar Mani, Giovanni Lentini, et al.
Molecules (Basel, Switzerland)|November 16, 2016
The Chemistry and Pharmacology of Citrus LimonoidsRoberta Gualdani, Maria Maddalena Cavalluzzi, Giovanni Lentini, et al.
Biophysical Chemistry|July 5, 2017
Discovery of a new mexiletine-derived agonist of the hERG K<sup>+</sup> channelRoberta Gualdani, Maria Maddalena Cavalluzzi, Francesco Tadini-Buoninsegni, et al.
Molecules (Basel, Switzerland)|July 26, 2020
From Riluzole to Dexpramipexole via Substituted-Benzothiazole Derivatives for Amyotrophic Lateral Sclerosis Disease Treatment: Case StudiesSerge Mignani, Jean-Pierre Majoral, Jean-François Desaphy, et al.
Expert Opinion on Drug Discovery|August 18, 2017
Ligand efficiency metrics in drug discovery: the pros and cons from a practical perspectiveMaria Maddalena Cavalluzzi, Giuseppe Felice Mangiatordi, Orazio Nicolotti, et al.
Pageof 11